Intratracheal Administration of Dry Powder Formulation in Mice

J Vis Exp. 2020 Jul 25:(161). doi: 10.3791/61469.

Abstract

In the development of inhalable dry powder formulations, it is essential to evaluate their biological activities in preclinical animal models. This paper introduces a noninvasive method of intratracheal delivery of dry powder formulation in mice. A dry powder loading device that consists of a 200 µL gel loading pipette tip connected to an 1 mL syringe via a three-way stopcock is presented. A small amount of dry powder (1-2 mg) is loaded into the pipette tip and dispersed by 0.6 mL of air in the syringe. Because pipette tips are disposable and inexpensive, different dry powder formulations can be loaded into different tips in advance. Various formulations can be evaluated in the same animal experiment without device cleaning and dose refilling, thereby saving time and eliminating the risk of cross-contamination from residual powder. The extent of powder dispersion can be inspected by the amount of powder remaining in the pipette tip. A protocol of intubation in mouse with a custom-made light source and a guiding cannula is included. Proper intubation is one of the key factors that influences the intratracheal delivery of dry powder formulation to the deep lung region of the mouse.

Publication types

  • Research Support, Non-U.S. Gov't
  • Video-Audio Media

MeSH terms

  • Administration, Inhalation
  • Animals
  • Catheterization
  • Drug Compounding*
  • Dry Powder Inhalers*
  • Lung / pathology
  • Mice, Inbred BALB C
  • Particle Size
  • Powders
  • RNA, Messenger / administration & dosage

Substances

  • Powders
  • RNA, Messenger